Power spectrum components were lower in AD patients compared to controls at rest. During the tilt test, there were no changes in the LF or HF components in AD patients while controls experienced an increase in the LF components and a decrease in the HF component. This was only seen in patients who underwent the cholinesterase inhibitor treatment during the tilt test. This evidence concerns the gene BCHE and Alzheimer disease.